Michael H. Gerber

2.6k total citations · 1 hit paper
37 papers, 1.8k citations indexed

About

Michael H. Gerber is a scholar working on Oncology, Genetics and Surgery. According to data from OpenAlex, Michael H. Gerber has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Genetics and 8 papers in Surgery. Recurrent topics in Michael H. Gerber's work include Pancreatic and Hepatic Oncology Research (10 papers), Mesenchymal stem cell research (9 papers) and Traumatic Brain Injury and Neurovascular Disturbances (5 papers). Michael H. Gerber is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Mesenchymal stem cell research (9 papers) and Traumatic Brain Injury and Neurovascular Disturbances (5 papers). Michael H. Gerber collaborates with scholars based in United States, Switzerland and Germany. Michael H. Gerber's co-authors include Erik J. Kobylarz, Kenneth B. Baker, Bob Eisenberg, Brandon M. Fritz, Joseph J. Fins, Jonathan D. Victor, Sierra Farris, Kathleen Kalmar, Nicholas D. Schiff and Jane M. O'Connor and has published in prestigious journals such as Nature, Nature Communications and PLoS ONE.

In The Last Decade

Michael H. Gerber

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Behavioural improvements with thalamic stimulation after severe traumatic brain injury

2007 660 citations Michael H. Gerber et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael H. Gerber United States	20	445	397	378	329	316	37	1.8k
G. Tomei Italy	27	699 1.6×	501 1.3×	321 0.8×	348 1.1×	67 0.2×	79	2.1k
Martin Savard Canada	20	267 0.6×	207 0.5×	274 0.7×	210 0.6×	109 0.3×	51	1.2k
Maurizio Iacoangeli Italy	27	705 1.6×	491 1.2×	161 0.4×	342 1.0×	80 0.3×	115	2.0k
Dar‐Ming Lai Taiwan	22	200 0.4×	134 0.3×	357 0.9×	315 1.0×	75 0.2×	71	1.8k
Lothar Resch Canada	21	742 1.7×	332 0.8×	253 0.7×	285 0.9×	89 0.3×	43	1.8k
Efstathios Boviatsis Greece	24	812 1.8×	516 1.3×	425 1.1×	87 0.3×	43 0.1×	79	1.8k
Chiara Zecca Switzerland	24	736 1.7×	182 0.5×	515 1.4×	115 0.3×	93 0.3×	129	2.7k
Eric M. Horn United States	24	460 1.0×	303 0.8×	143 0.4×	118 0.4×	112 0.4×	69	2.2k
Stefan Kunze Germany	20	656 1.5×	327 0.8×	169 0.4×	291 0.9×	79 0.3×	69	2.0k
Lan Zhou United States	30	357 0.8×	202 0.5×	1.6k 4.2×	356 1.1×	46 0.1×	66	3.0k

Countries citing papers authored by Michael H. Gerber

Since Specialization

Citations

This map shows the geographic impact of Michael H. Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Gerber more than expected).

Fields of papers citing papers by Michael H. Gerber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Gerber. The network helps show where Michael H. Gerber may publish in the future.

Co-authorship network of co-authors of Michael H. Gerber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Gerber. A scholar is included among the top collaborators of Michael H. Gerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Gerber. Michael H. Gerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gerber, Michael H., Matthew A. Schaich, Sua Myong, et al.. (2025). Therapeutic 6-thio-deoxyguanosine inhibits telomere elongation in cancer cells by inducing a non-productive stalled telomerase complex. Nature Communications. 17(1). 6–6.

Möller, Kathleen, Michael Hocke, Simon Everett, et al.. (2024). Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine guidelines: Rare pancreatic tumors, ultrasound and contrast-enhanced ultrasound features—Malignant mesenchymal tumors. Endoscopic Ultrasound. 13(2). 55–64. 1 indexed citations

Möller, Kathleen, Axel Löwe, Christian Jenssen, et al.. (2024). Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine contrast-enhanced ultrasound guidelines. Rare pancreatic tumors, imaging features on transabdominal ultrasound and EUS with contrast enhancement: Rare epithelial pancreatic tumors: solid pseudopapillary neoplasm, acinar cell carcinoma, mixed neuroendocrine-non-neuroendocrine neoplasms, some rare subtypes of pancreatic adenocarcinoma and pancreatoblastoma. Endoscopic Ultrasound. 13(3). 129–144. 2 indexed citations

Möller, Kathleen, Christian Jenssen, Barbara Braden, et al.. (2024). Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine contrast-enhanced ultrasonography guidelines: multiparametric imaging and EUS-guided sampling in rare pancreatic tumors. Mesenchymal pancreatic tumors of intermediate biological behaviour. Endoscopic Ultrasound. 13(3). 145–153.

Herremans, Kelly M., Andrea N. Riner, Xiang‐Yang Lou, et al.. (2022). The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma. Neoplasia. 28. 100789–100789. 23 indexed citations

Gerber, Michael H. & Stephanie G. Worrell. (2022). Indocyanine Green Use During Esophagectomy. Surgical Oncology Clinics of North America. 31(4). 609–629. 3 indexed citations

Underwood, Patrick W., Miles E. Cameron, Michael H. Gerber, et al.. (2020). Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia. Cancers. 12(2). 329–329. 20 indexed citations

Biel, Thomas, Baikuntha Aryal, Michael H. Gerber, et al.. (2020). Mitochondrial dysfunction generates aggregates that resist lysosomal degradation in human breast cancer cells. Cell Death and Disease. 11(6). 460–460. 21 indexed citations

Underwood, Patrick W., Michael H. Gerber, & Steven J. Hughes. (2019). Pitfalls of minimally invasive pancreatoduodenectomy. PubMed. 2. 2–2. 7 indexed citations

10.

Underwood, Patrick W., Michael H. Gerber, Kathy Nguyen, et al.. (2019). Protein Signatures and Tissue Diagnosis of Pancreatic Cancer. Journal of the American College of Surgeons. 230(1). 26–36e1. 7 indexed citations

11.

Gerber, Michael H., Patrick W. Underwood, Sarah M. Judge, et al.. (2018). Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine. International Journal of Molecular Sciences. 19(12). 3836–3836. 15 indexed citations

12.

Cai, Weijing, Ranjala Ratnayake, Michael H. Gerber, et al.. (2018). Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model. Investigational New Drugs. 37(2). 364–374. 24 indexed citations

13.

Rubiano, Andrés M., Daniel Delitto, Song Han, et al.. (2017). Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties. Acta Biomaterialia. 67. 331–340. 95 indexed citations

14.

Go, Kristina L., Daniel Delitto, Sarah M. Judge, et al.. (2017). Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease. Pancreas. 46(6). 813–819. 35 indexed citations

15.

Delitto, Daniel, Andrea E. Delitto, Kien Pham, et al.. (2016). Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment. Cancer Research. 77(3). 672–683. 23 indexed citations

16.

Menge, Tyler D., Michael H. Gerber, Kathryn Wataha, et al.. (2012). Human Mesenchymal Stem Cells Inhibit Endothelial Proliferation and Angiogenesis via Cell–Cell Contact Through Modulation of the VE-Cadherin/β-Catenin Signaling Pathway. Stem Cells and Development. 22(1). 148–157. 62 indexed citations

17.

Pati, Shibani, Michael H. Gerber, Tyler D. Menge, et al.. (2011). Bone Marrow Derived Mesenchymal Stem Cells Inhibit Inflammation and Preserve Vascular Endothelial Integrity in the Lungs after Hemorrhagic Shock. PLoS ONE. 6(9). e25171–e25171. 121 indexed citations

18.

Pati, Shibani, Aarif Y. Khakoo, Jing Zhao, et al.. (2010). Human Mesenchymal Stem Cells Inhibit Vascular Permeability by Modulating Vascular Endothelial Cadherin/β-Catenin Signaling. Stem Cells and Development. 20(1). 89–101. 92 indexed citations

19.

Walker, Peter A., Shinil K. Shah, Fernando Jiménez, et al.. (2010). Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: Preserving the blood brain barrier via an interaction with splenocytes. Experimental Neurology. 225(2). 341–352. 117 indexed citations

20.

Walker, Peter A., Fernando Jiménez, Michael H. Gerber, et al.. (2009). Effect of Needle Diameter and Flow Rate on Rat and Human Mesenchymal Stromal Cell Characterization and Viability. Tissue Engineering Part C Methods. 16(5). 989–997. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact